Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin I Johnston

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Blood Pressure|April 21, 2017
Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic ConceptColin I Johnston
Trends in Endocrinology and Metabolism: TEM|April 28, 2004
ACE2, a new regulator of the renin-angiotensin systemLouise M Burrell, Colin I Johnston, Christos Tikellis, et al.
Journal of Clinical Nursing|December 17, 2008
Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease preventionMelinda J Carrington, Claudia Retegan, Colin I Johnston, et al.
Cardiovascular Research|June 14, 2002
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibitionMareo Naitoh, John Risvanis, Leanne C Balding, et al.
Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.
Journal of the American Society of Hypertension : JASH|December 19, 2012
Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertensionLouise M Burrell, John Risvanis, Rachael G Dean, et al.
Clinical Science (London, England : 1979)|May 14, 2003
Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the ratEiji Kubota, Rachael G Dean, Richard A Hubner, et al.
The International Journal of Biochemistry & Cell Biology|April 5, 2003
Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibitionMaurice E Fabiani, David J Hawkes, Albert G Frauman, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathyChristos Tikellis, Colin I Johnston, Josephine M Forbes, et al.
American Journal of Hypertension|November 20, 2013
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure studyEnayet K Chowdhury, Alice Owen, Zanfina Ademi, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Blood Pressure|April 21, 2017
Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic ConceptColin I Johnston
Trends in Endocrinology and Metabolism: TEM|April 28, 2004
ACE2, a new regulator of the renin-angiotensin systemLouise M Burrell, Colin I Johnston, Christos Tikellis, et al.
Journal of Clinical Nursing|December 17, 2008
Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease preventionMelinda J Carrington, Claudia Retegan, Colin I Johnston, et al.
Cardiovascular Research|June 14, 2002
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibitionMareo Naitoh, John Risvanis, Leanne C Balding, et al.
Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.
Journal of the American Society of Hypertension : JASH|December 19, 2012
Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertensionLouise M Burrell, John Risvanis, Rachael G Dean, et al.
Clinical Science (London, England : 1979)|May 14, 2003
Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the ratEiji Kubota, Rachael G Dean, Richard A Hubner, et al.
The International Journal of Biochemistry & Cell Biology|April 5, 2003
Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibitionMaurice E Fabiani, David J Hawkes, Albert G Frauman, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathyChristos Tikellis, Colin I Johnston, Josephine M Forbes, et al.
American Journal of Hypertension|November 20, 2013
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure studyEnayet K Chowdhury, Alice Owen, Zanfina Ademi, et al.
Pageof 3